大喜多 肇

Medicine & Life Sciences

1. Wilms Tumor 100%
2. Neoplasms 78%
3. Ewing's Sarcoma 78%
4. Induced Pluripotent Stem Cells 73%
5. Japan 51%
6. B-Lymphoid Precursor Cells 48%
7. Precursor Cell Lymphoblastic Leukemia-Lymphoma 45%
8. Clear Cell Sarcoma 41%
9. bcl-2 Genes 40%
10. stage-specific embryonic antigen-4 39%
11. Kidney 37%
12. Embryonal Carcinoma Stem Cells 36%
13. Rhabdoid Tumor 35%
14. Genes 33%
15. Cell Line 31%
16. Pediatrics 29%
17. Glycosphingolipids 29%
18. Apoptosis 28%
19. RNA-Binding Protein EWS 25%
20. Platelet-Derived Growth Factor beta Receptor 25%
21. Monoclonal Antibodies 25%
22. Neuroblastoma 24%
23. Embryonic Stem Cells 22%
24. Embryonic Development 21%
25. Epitopes 20%
26. Osteosarcoma 20%
27. Shiga Toxin 1 19%
28. Drug Therapy 19%
29. Histology 19%
30. Child 19%
31. Neurofibrosarcoma 19%
32. Gene Fusion 18%
33. Mesenchymal Stem Cells 18%
34. Recurrence 18%
35. Stem Cells 17%
36. EWS-FLI fusion protein 17%
37. Epigenomics 17%
38. Sarcoma 16%
39. paragloboside 16%
40. Therapeutics 16%
41. Rhabdomyosarcoma 16%
42. Proteins 15%
43. B-Lymphocytes 15%
44. Lung 15%
45. Prostatic Neoplasms 14%
46. Methylation 14%
47. Survival 14%
48. Vincristine 13%
49. Mutation 13%
50. DNA Methylation 13%